FDA’s Drug Center Creates New Artificial Intelligence Council To Boost Coordination

FDA’s drug center has set up a new Artificial Intelligence Council to provide oversight and coordination of drug-related AI activities and advance emerging technologies. The council, FDA said in an announcement Thursday (Aug. 29), will help the Center for Drug Evaluation and Research (CDER) coordinate compliance with the Biden administration's AI executive order as lawmakers struggle with drafting comprehensive AI legislation. The move by CDER comes as top FDA officials acknowledge the growing use of AI in drug development is...